TGM2 and breast carcinoma: Further, to evaluate the crosslinking i.e. transamidating activity of TG2 (stroma/cytoplasm), we determined the expression of N-epsilon gamma-glutamyl lysine amino residues (to detect any potential TG2-mediated protein crosslinking events) in the same cohort of the breast cancers using immunohistochemistry.